Response to pyridoxine in CACNA1A epilepsy-ataxia does not imply a causal effect

Affiliations

¹ Department of Paediatric Neurology, Evelina London Children's Hospital, London, United Kingdom; Department of Basic & Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; MRC Centre for Neurodevelopmental Disorders, King's College London, London, United Kingdom; King's College Hospital, London, United Kingdom. Electronic address: deb.pal@kcl.ac.uk.
² Department of Paediatric Neurology, Evelina London Children's Hospital, London, United Kingdom.

Free article

Comment

Deb K Pal et al. Seizure. 2021 Oct.

Free article

. 2021 Oct:91:196-197.

doi: 10.1016/j.seizure.2021.06.031. Epub 2021 Jun 29.

¹ Department of Paediatric Neurology, Evelina London Children's Hospital, London, United Kingdom; Department of Basic & Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; MRC Centre for Neurodevelopmental Disorders, King's College London, London, United Kingdom; King's College Hospital, London, United Kingdom. Electronic address: deb.pal@kcl.ac.uk.
² Department of Paediatric Neurology, Evelina London Children's Hospital, London, United Kingdom.

No abstract available

Keywords: CACNA1A; Pyridoxine.

Comment on

Systematic Review of N-of-1 Studies in Rare Genetic Neurodevelopmental Disorders: The Power of 1.
Müller AR, Brands MMMG, van de Ven PM, Roes KCB, Cornel MC, van Karnebeek CDM, Wijburg FA, Daams JG, Boot E, van Eeghen AM. Müller AR, et al. Neurology. 2021 Mar 16;96(11):529-540. doi: 10.1212/WNL.0000000000011597. Epub 2021 Jan 27. Neurology. 2021. PMID: 33504638 Free PMC article.